Longevity Foundation to Fund Geroscience Research with €860M
The newly-created Longevity Science Foundation aims to extend the human lifespan to more than 120…
The newly-created Longevity Science Foundation aims to extend the human lifespan to more than 120…
Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts…
Although most gene therapy still relies on non-infectious viral vectors for delivery, a recent venture…
As pressure mounts to tackle climate change, the Danish Novo Nordisk Foundation has granted €84.7M…
After years of under-fulfilled promise, breath tests for cancer, liver disease, and respiratory conditions appear…
Despite the urgent danger of antibiotic resistance, investments into European biotech antibiotic players have remained…
This week’s €64M Series B fundraise from the French firm TreeFrog Therapeutics is the latest…
As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series…
UK and German companies led the European biotech funding race in August, specializing in cell…
Johnson & Johnson became the latest company to have a failed vaccine trial against HIV…
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
The FDA has given the green light to Danish company Ascendis Pharma for the first…